Cenra

Cenra EPS

The Earnings per Share (EPS) of Cenra (3716.TW) as of Nov 9, 2026 is 2.05 TWD. In the previous year, Earnings per Share (EPS) was 2.13 TWD — a change of -3.57% (lower).

EPS

2.05TWD

YoY

-3.57%

Last updated:

Earnings per Share (EPS) of Cenra is 2025 2.05 TWD. Earnings per Share (EPS) of Cenra was 2024 2.13 TWD. It decreases by -3.57% lower compared to the previous year.

The Cenra EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
1.24 TWD
Jan 1, 2019
1.29 TWD
Jan 1, 2020
1.86 TWD
Jan 1, 2021
3.47 TWD
Jan 1, 2022
3.20 TWD
Jan 1, 2023
2.16 TWD
Jan 1, 2024
2.13 TWD
Jan 1, 2025
2.05 TWD
The Cenra EPS history
YEAREPSYoY
2.05TWD-3.57%
2.13TWD-1.53%
2.16TWD-32.51%
3.20TWD-7.72%
3.47TWD+86.80%
1.86TWD+43.63%
1.29TWD+4.01%
1.24TWD+19.03%
1.05TWD-0.79%
1.05TWD-11.45%
1.19TWD+1.72%
1.17TWD+44.73%
0.81TWD-25.40%
1.08TWD+5.30%
1.03TWD-14.65%
1.21TWD-7.61%
1.30TWD+513.77%
0.21TWD-72.24%
0.77TWD-10.40%
0.85TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cenra Stock analysis

What does Cenra do? Cenra Inc generates revenue through its subsidiaries that develop, manufacture, and sell pharmaceuticals, agricultural and livestock drugs, personal hygiene, and health products. The company offers human medicines including prescription, over-the-counter, and disease treatment products, medical equipment such as blood pressure monitors and blood glucose meters, animal medicines and feed additives, and daily necessities like oral hygiene products, hand sanitizers, and skin care items. These products are sold under the company's own brand portfolio, targeting consumers, healthcare providers, and veterinary markets. The company's business model focuses on integrated product development and distribution across multiple health and wellness segments. Cenra Inc's product segments include human pharmaceuticals, medical devices, animal health solutions, and personal care items. The human medicine segment covers prescription and over-the-counter drugs, while medical devices include blood pressure monitors and artificial joints. Animal health products consist of medicines, supplementary feeds, and feed additives for disease prevention and nutrition. Personal care products range from oral hygiene to skin care, targeting individual consumers seeking health and wellness solutions. The company's revenue streams are derived from direct sales of these diverse product categories to end-users and healthcare institutions. The company's subsidiaries handle the full value chain from development to sales, ensuring control over product quality and market positioning. By offering a comprehensive range of health-related products, Cenra Inc serves multiple customer segments including individual consumers for personal care, hospitals and clinics for medical equipment, and veterinary clinics for animal health products. This diversified approach allows the company to leverage cross-selling opportunities and maintain steady revenue streams across different market segments. Cenra is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cenra stock

Earnings per Share (EPS) of Cenra is 2.05 TWD in 2025.

Earnings per Share (EPS) of Cenra changed from 2.13 TWD to 2.05 TWD, representing a -3.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Cenra since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Cenra

All Key Metrics — Cenra